Axicabtagene Ciloleucel Expanded Access Study

首次发布于 2017 年 5 月 15 日

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

计划入组 60 人 · 首次发布于 2020 年 3 月 24 日

Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma

计划入组 30 人 · 首次发布于 2025 年 2 月 13 日

Axicabtagene ciloleucel(Yescarta)

Rx

Ranicabtagene autoleucel

Axicabtagene Ciloleucel Approved for Second-Line LBCL Treatment

Real-World Study Affirms Axicabtagene Ciloleucel's Efficacy in LBCL, Expanding Patient Eligibility

Axicabtagene Ciloleucel Shows Promise as Second-Line Therapy for Aggressive B-Cell Lymphoma